| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | cabozantinib | CTRPv2 | pan-cancer | AAC | -0.023 | 0.5 |
| mRNA | ML083 | CTRPv2 | pan-cancer | AAC | 0.024 | 0.5 |
| mRNA | alvocidib | CTRPv2 | pan-cancer | AAC | 0.031 | 0.6 |
| mRNA | ML334 diastereomer | CTRPv2 | pan-cancer | AAC | -0.028 | 0.6 |
| mRNA | BRD-K34222889 | CTRPv2 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | Bryostatin 1 | FIMM | pan-cancer | AAC | 0.083 | 0.6 |
| mRNA | Vorinostat | FIMM | pan-cancer | AAC | -0.092 | 0.6 |
| mRNA | 17-AAG | FIMM | pan-cancer | AAC | -0.1 | 0.6 |
| mRNA | S-Trityl-L-cysteine | GDSC1000 | pan-cancer | AAC | -0.031 | 0.6 |
| mRNA | SGX-523 | CTRPv2 | pan-cancer | AAC | -0.022 | 0.6 |